Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,163
Recruiting: 2,261
Ph III recruiting: 270
Growth YoY: +12.5%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 4,301–4,350 of 4,807 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02094105	Endoscopic Screening on Esophageal Cancer	completed	N/A	45,386	Chinese Academy of Medical SciencesOTHER	1	Mar 21, 2014	clinicaltrials
NCT00356460	Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma	completed	Phase 1	29	Genzyme, a Sanofi CompanyINDUSTRY	1	Mar 19, 2014	clinicaltrials